Dr. John Bell receives European Society for Gene and Cell Therapy Public and Patient Engagement Award
The ESGCT seeks to honour impactful, significant and lasting contributions to the field of gene and cell therapy. This award recognizes outstanding contribution to, and participation in, public and patient stakeholder engagement.
Dr. John Bell is a senior scientist in the Cancer Therapeutics Program of OHRI and a professor in the Departments of Medicine and Biochemistry, Microbiology and Immunology. Dr. Bell is also the Scientific Director of BioCanRx, a Network Centre of Excellence, through which he is recognized for his outstanding work toward engaging patients, establishing dialogue and generating learning. He is committed to engaging research and patient partners in all aspects of the research process and supporting researcher-patient collaborations.